Brazil’s Non-Small-Cell Lung Cancer Drug Market will Reach $240 Million by 2014

Published July 6, 2010

Brazil’s Non-Small-Cell Lung Cancer Drug Market will Reach 0 Million by 2014
Decision Resources, one of the world’s leading research and advisory firms focusing on pharmaceutical and healthcare issues, forecasts that the non-small-cell lung cancer drug market in Brazil will reach 0 million by 2014.
Read more on PR Newswire via Yahoo! Finance

Sangamo BioSciences Receives Michael J. Fox Foundation Funding To Develop Novel Drug For The Treatment Of Parkinson’s …
Sangamo BioSciences, Inc. (Nasdaq: SGMO) announced today that it has been awarded a second round of funding by The Michael J. Fox Foundation for Parkinson’s Research (MJFF) to support studies in non-human primates for the development of a ZFP Therapeutic™ to treat Parkinson’s disease (PD).
Read more on BioresearchOnline